News

Join Us for the Bio-Monitor (Astroskin) launch to Space on December 4th!

We are happy to invite you to our live webcast on December 4th, that will broadcast the Astroskin launch to Space aboard Space X Dragon Cargo vehicle. Before the launch, Hexoskin's co-founders will discuss the history of the development of the Bio-Monitor system as well as a few case applications in Space and on Earth.

The Astroskin system is based on the Bio-Monitor designed for the Canadian Space Agency (CSA) to monitor the astronauts’ health in space on the International Space Station (ISS). It will be operational in space and available for all ISS participating countries to conduct space research for the next five years.
 
LIVE WEBCAST:
Astroskin Launch to the ISS aboard SpaceX Dragon Cargo
December 4, 2018, at 1:25 PM (EST)** - via the Zoom Video Conferencing software
** In case of postponement of the launch, you will receive a notification
with a new broadcast schedule.

Speakers: 
- Pierre-Alexandre Fournier, CEO & Co-Founder, Hexoskin
- Jean-François Roy, CTO & Co-Founder, Hexoskin 


Guest Speaker: 
- Professor Richard L. Hughson Ph.D., University of Waterloo

If you are unable to attend, you can still register and we will send you the recorded webcast by email afterward. 

We look forward to your presence for this special event!



About Hexoskin

Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.

Contact our team to order Astroskin

Fierce Pharma: Pharma has a real-world problem, and it's the lag in its sensor adoption

Adoption of mobile and connected health tech in clinical trials is a real-world challenge for pharmaceutical companies. Our CEO Pierre-Alexandre Fournier has shared his thoughts recently about the adoption of mobile and connected health tech with Fierce Pharma.

"The industry needs to get with it now or pay for it later—literally. The reason? Sensor tech will be adopted faster at a large scale in healthcare than in pharma trials, and that means “the drugs you are developing today are going to be seen with tools that you are not using in your trials right now.”  That could cost drugmakers billions of dollars if they launch products only to find that monitoring tech turns up real-world outcomes that don’t meet payers’ standards."

Read more on Fierce Pharma.

 

Presenting An AI Approach to Maximize Pipeline Value at DPharm

This year again, Hexoskin is attending the DPharm Conference, taking place in Boston September 6-8.


On September 7th, Hexoskin's CEO Pierre-Alexandre Fournier, will talk about opportunities for Pharma companies to uncover new insights from the data they have collected from trials, and how to take advantage of AI/machine learning advances to maximize pipeline value.

Hexoskin has been developing machine learning and data mining algorithms since 2006. With its wearable health sensors, it has accumulated terabytes of health data from thousands of users. The company has a long experience in dealing with large datasets, and is working with healthcare and pharmaceutical organizations to unlock value from clinical trials data, health research, and more.

 

View full article →

Hexoskin Presents Tools for Chronic Care at the AI in Healthcare Summit in San Francisco

Hexoskin is attending the AI in Healthcare Summit in San Francisco this week to present its connected health platform and healthcare AI architecture on Monday, June 26th.

The current hospital system has been built around the treatment of acute illness: emergencies, injuries, infections, etc. Chronic diseases are changing healthcare, and we are now entering a future in which care delivery is becoming decentralized, where communication between health professionals and patients is being facilitated by technology, leading to many potential advancements in prevention, treatment of chronic illness, and much more.

In his talk, Hexoskin's CEO Pierre-Alexandre Fournier discusses the specific tools enabling these advancements, what challenges exist in using health data for AI, and how healthcare professionals can leverage these new technologies to improve the quality of life for chronically ill patients.

Hexoskin at the AI in Healthcare Summit - San Francisco June 26-27, 2017

The Hexoskin software research platform is designed to generate continuous health data for the development of Artificial Intelligence (machine learning) algorithms for chronic diseases management. Hexoskin also offers AI and data science services to healthcare and pharma companies.

Hexoskin is the world leader in smart clothing and body sensing technologies. The company has announced last year it will equip the International Space Station (ISS) with a bio-monitoring system for astronauts in collaboration with NASA and the Canadian Space Agency.

The Montreal Heart Institute is currently completing a clinical trial with Hexoskin biometric shirts with angina patients undergoing therapy. One of the goals of the study is to develop a new vitality index using Hexoskin biometric shirts to assess angina and to monitor the rehabilitation of cardiac patients.

About Hexoskin

Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by space and defense agencies, sports scientists, and thousands of health professionals and health researchers all over the world. The Hexoskin connected platform provides a new, convenient way to understand human health in real-life environments. For more information, write us at contact@hexoskin.com, and visit www.hexoskin.com and @Hexoskin on Twitter.

 

CAUTION - Hexoskin products and services are not intended, and should not be used to investigate, diagnose, monitor, treat or prevent disease or other medical conditions nor to provide information for medical or diagnostic purposes.

Hexoskin Demonstrates its Connected Health Platform and Biometric Shirt at BIO 2017 in San Diego

Hexoskin is attending the 2017 BIO conference in San Diego this week, and will be demonstrating its connected health platform and biometric shirt at the Quebec pavilion (booth 4315).

The Hexoskin open-data platform enables the development of new digital markers, third-party device integration, ePROs, artificial intelligence and application-specific development.

In order to meet clinical trial development requirements, Hexoskin works in partnership with pharma and biotechs to design efficient protocols for continuous patient monitoring. Clinical areas of interest include those with a need for longitudinal studies in cardiology, respiratory, sleep, CNS, activity, stress, mental illness, etc. 

The Hexoskin software research platform is designed to generate continuous health data for the development of Artificial Intelligence (machine learning) algorithms for chronic diseases management. Hexoskin also offers AI and data science services to pharma and biotech companies.


View full article →

Hexoskin, a non-invasive system, used to monitor sleep and save costs

As seen in the AARP document, The Longevity Economy – How People Over 50 are Driving Economic and Social Value in the U.S., ‘’early experiments also indicate that Hexoskin may facilitate remote monitoring/telehealth—in uses ranging from ambient assisted living (AAL) to sleep health (Banejee, T. et al., 2015) (…) This reduces both public and individual healthcare costs, and is minimally intrusive for patients.’’

 



Hexoskin is the only clinically validated system that continuously 
records ECG with respiratory lung functions and daily/sleep activities. It is used more and more to assess sleep quality at home and in clinical studies. In fact, all the data recorded with Hexoskin are important to consider when it comes to wellness and longevity.

Here is the link to the AARP document: The Longevity Economy

-----------------------------------------------------------------------------------------------------------------------------------------


Sleep disorders can have a dramatic impact on a person's health. According to the American College of Cardiology, obstructive sleep apnea affects more than 12 millions American adults which most of the time aren't diagnosed. The relationship between sleep disorders and cardiovascular diseases is well documented.

Hexoskin's CEO Pierre-Alexandre Fournier talks about Montreal’s advantages for Health Technology companies

In this new entrepreneurial capsule from Montreal InVivo, Pierre-Alexandre explains his motivations and goals as an entrepreneur in health technologies. He puts forward the help given by different organizations for new tech businesses, and programs available to support for business growth. He also points to the exceptionally skilled workforce in Montreal, a city with more than 170,000 college students in 11 universities, recently rated #1 city in the world for college students.

''A whole toolbox to help entrepreneurs get what they need to make their business grow''

 

About Montreal InVivo:

''Montréal InVivo is an economic development organization dedicated to the creation of a business environment that fosters innovation and growth of companies and organizations in the life sciences and health technologies (LSHT) sector.''
www.montreal-invivo.com

About Hexoskin:

''Founded in Montreal in 2006, Hexoskin's mission is to record and organize personal information to make it accessible and useful. The company's co-founders realized that body-worn sensors could capture precise biometric data inside comfortable smart clothing. The company released the first innovative Hexoskin Smart Shirt in 2013.''

2 nominations for Hexoskin at the 4th Edition of the Connected Objects Awards NPA in Paris

The Ceremony of the Connected Objects Awards is an initiative of the NPA Conseil. The aim of this initiative is to distinguish the most innovative connected objects and services. It will take place tomorrow May 16th in Paris. Hexoskin has 2 nominations in the category Wellness, Health and Body-control: Monitoring of physical activity, coaching and sports practice, and object or service for the elderly or handicapped. 

https://www.trophee-objets-connectes.fr/
 

The Laureates will be announced tomorrow afternoon at La Maison des Travaux Publics (Paris 8e). Let's keep in touch!

Hexoskin discusses health innovation and medical procurement at ProcurMed 2017

ProcurMed 2017, a Canadian MedTech Procurement Forum, took place today May 11th in Montreal. Our CEO Pierre-Alexandre Fournier shared experiences and lessons learned in working with hospitals in Canada and the United States.

Procurmed 2017 Montreal Canada

Hospital procurement and innovation departments, payors, and medical devices and health IT companies from Ontario, Quebec, Massachusetts, Vermont, and other states shared ideas on how to make it easier for innovative technologies to go through the procurement process. We talked shared risk, integrating pilots in procurement, and how to do procurement in a value-based healthcare system.


Procurmed 2017 Montreal Canada Panel

From left to right on the picture: Sophie Cerny (Québec government office in Boston), Stuart Kozlick (Kinova), and Pierre-Alexandre Fournier (Hexoskin)

Hexoskin in Japan

Hexoskin presented its technology for health monitoring at the Wearable Expo at Tokyo Big Sight this week. We were present on the show floor with our Japanese partners Kissei Comtec, and had the chance to visit Tokyo and Matsumoto.

Dozens of top health research organizations and sports performance labs in Japan use Hexoskin's open data platform for physiology monitoring. If you're in Japan you can contact Kissei Comtec for Japanese training and support.

Tokyo Big Sight (東京ビッグサイト), officially known as Tokyo International Exhibition Center (東京国際展示場), is a convention and exhibition center in Tokyo, Japan, and the largest one in the country.